Abstract:OBJECTIVE:To search the role of Helicobacter pylori (H. pylori) in the progression of gastric carcinogenesis.METHODS:A cohort study was conducted by cluster randomized sampling in Linqu County, a rural area in Shandong Province in northeast China, where the mortality of gastric cancer (GC) is among the highest in the world. In 1989-1990, a gastroscopic examination and serum test was launched among subjects aged 35-64 from 14 randomized villages. Histological diagnosis of gastric mucosa and enzyme-linked immunosorbent assay was used to detect gastric lesions and anti-H. pylori of all participants. A repeated gastroscopic screening was offered to all cohort members in 1994 and 1999 respectively, and all the GC cases, regardless of natural ones or ones by gastroscopy, were registered in the follow-up periods.RESULTS:Fifty-eight cases of GC were identified in 2469 subjects during the 10-year follow-up, 44 were observed in 1603 H. pylori-positive persons (2.74%) and 14 in 866 H. pylori-negative persons (1.62%). The incidence rate of GC in H. pylori-positive is significantly higher than in H. pylori-negative (OR = 1.871, 95% CI: 1.012 - 3.459). There was no significant difference in the progression of gastric carcinogenesis between H. pylori-positive and H. pylori-negative (P > 0.05) among subjects with normal or superficial gastritis (SG) at baseline. In contrast, the significant difference was found in baseline chronic gastritis (CAG) group (P < 0.01), and the GC incidence rate in H. pylori-positive (7/615) is higher than in H. pylori-negative (0/470, P = 0.019). The difference of gastric lesions between H. pylori-positive and H. pylori-negative in subjects with intestinal metaplasia (IM) and dysplasia (DYS) at baseline was statistically significant after a 10-year follow-up (P < 0.05, P < 0.01, respectively), but the GC incidence rate in H. pylori-positive is similar to the rate in H. pylori-negative at the two groups (17/573 and 7/224 in IM group, P = 0.907; 19/368 and 7/122 in DYS group, P = 0.806).CONCLUSIONS:H. pylori is a key risk factor that prompts the transition from chronic atrophic gastritis to advanced precancerous lesions and influences the whole progression of precancerous gastric lesions. H. pylori, perhaps can not cause GC directly, increases the risk of GC in company with other carcinogens. H. pylori seemingly has no important effect on the development of GC when gastric mucosa is normal or superficial gastritis, but this conclusion is required to be further confirmed.

Detection of H.pylori DNA in Gastric Epithelial Cells by in Situ Hybridization.

Distribution of H.pylori Antigens in Gastric Mucosa and Its Significance.

Effect of Helicobacter Pylori Infection on Gastric Epithelial Proliferation in Progression from Normal Mucosa to Gastriccarcinoma.

Helicobacter Pylori Antibodies in Relation to Precancerous Gastric Lesions in a High-Risk Chinese Population.

Effects of H. Pylori Infection on Cell Kinetics of Gastric Epithelial Cells

Helicobacter pylori stimulates DNA synthesis in a small intestinal cell line in vitro

Effects of Helicobacter Pylori on the Expression of Catalytic Subunit of the DNA-dependent Protein Kinase and Ku70/Ku80 Heterodimer in Gastric Mucosa Epithelial Cells in Vivo and in Vitro

Detection of Helicobacter Pylori DNA in Peripheral Blood from Patients with Peptic Ulcer or Gastritis.

[Helicobacter Pylori and the Progression of Gastric Cancer: a 10-Year Cohort Study].

Normal gastric tissue Helicobacter pylori infection is associated with epigenetic age acceleration, increased mitotic tick rate, tissue cell composition, and Natural Killer cell methylation alterations

[Detection and Analysis of Helicobacter Pylori in Oral Cavity and Stomach from Chronic Gastritis Patients].

Detection of Helicobacter pylori DNA in peripheral blood

Helicobacter pylori Infection, DNA Methylation, and Gastric Carcinogenesis

Investigation of H. Pylori and CagA Genes in Gastric Cancer with Different Parts, Dif-Ferention and Origin

Helicobacter pylori Infection and Gastric Precancerous Lesion

Effect of Helicobacter Pylori Infection on Gastric Epithelial Cell Proliferation

Alterations of Gastric Homeoprotein Expression in Helicobacter Pylori Infection, Incisural Antralisation, and Intestinal Metaplasia

Expression of P53 and iNOS in patients with Helicobacter pylori-associated gastric diseases

Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions.

H. pylori Infection and the Anatomic Distribution of Chronic Atrophic Gastritis in a Population at High Risk of Gastric Cancer

Proteomics-Based Identification and Analysis of Proteins Associated with Helicobacter Pylori in Gastric Cancer.